Fundraising Fox

Reconnect Labs

1 known investors

Find your way into Reconnect Labs

140 people in our graph share verified history with the Reconnect Labs team — schools, employers, funds. One of them is your warm intro.

Michael Zehnderunlockedknows Michael Kometer · together at EPFL (overlapped)
×4knows the team · via EPFL
knows the team · via SamanTree Medical
×6knows the team · via University of Duisburg-Essen

Reconnect Labs develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders, drawing on clinical drug development and psychiatric research. It operates in the neuropsychiatry and clinical drug development space.

BiotechDigital HealthHealthtechMental Health

Founders & leadership

MKMichael Kometer
Michael KometerinBoard Chairman & Co-founderBoard Chairman and Co-founder of Reconnect Labs, which develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders.

Investors · 1

LIONHEART VENTURESSan Francisco

Competitors · 1

by search overlap
Reunion Neuroscience3 shared keywordsReunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder. Its lead candidate, luvesilocin (RE104), is a short-duration prodrug of 4-OH-DiPT that targets the serotonin 2A receptor.

Companies competing with Reconnect Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Reconnect Labs do?
Reconnect Labs develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders, drawing on clinical drug development and psychiatric research. It operates in the neuropsychiatry and clinical drug development space.
Who founded Reconnect Labs?
Reconnect Labs was founded by Michael Kometer.
Who are Reconnect Labs's investors?
Reconnect Labs's investors include LIONHEART VENTURES.